NEWMEDS consortium aims to boost drug discovery in mental illness
A Lack of animal models and difficulties in proving early clinical efficacy are hampering discovery and development of psychiatric drugs according to new consortium, NEWMEDS.
Archives for November 15, 2010
Eden Biodesign becomes cGMP provider for PER.C6 technology
Crucell and Eden Biodesign have entered into an agreement that sees Eden become a provider of services of contract manufacturing services for Crucell's PER.C6 cell-line technology.
Forte Research Systems open office in India
Clinical software developer, Forte Research Systems, has opened a new office in Bangalore, India, to take advantage of growth in the clinical research industry on the sub-continent.
Appointments at Aqua Pharmaceuticals, Algeta ASA and Amarin – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Aqua Pharmaceuticals, Algeta ASA and Amarin.
Education of health conditions in RCTs boosts recruitment
Patient recruitment is boosted by health condition awareness strategies and financial incentives, according to research, but various methods of randomisation and consent design have no impact.
Drug delivery market to reach $199bn by 2016, says GBI Research
A report by GBI Research predicts the drug delivery market will grow by 10.3 per cent annually in the years leading up to 2016.
in-Pharmatechnologist looks at the latest news in drug delivery
Outsourcing-Pharma reviews the latest developments in drug delivery with news from HepaLife Technologies and Jeiven, SurModics and Edge, as well as EDAP, Epitarget AS and INSERM.
Joint API inspection pilot a success, says EMA
The European Medicines Agency (EMA) says 12-month API plant joint inspection programme has fostered greater collaboration between international drug industry regulators and cut the number of duplicate visits.